• Revenue Cycle Management
  • COVID-19
  • Diabetes Awareness Month
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Is MOC worth the time and effort it requires?

Article

Letter to the editor

In response to your excellent article on Maintenance of Certification (“MOC: Debate intensifies as Medicare penalties loom,” Medical Economics, June 25, 2013) I would like to ask Eric Holmboe, MD, if any evidence exists to show that all the work expected of diplomates achieves better outcomes for patients and physicians. Perhaps Holmboe can consider that the American Board of Internal Medicine Foundation has written that physicians should be skeptical of studies funded by the pharmaceutical industry. Does it follow that diplomates should be skeptical of studies funded by the American Board of Internal Medicine attempting to demonstrate any value to maintenance of certification? And if there is no conclusive evidence of MOC efficacy, should all the effort, time, and money spent on pursuing MOC continue?

Also, thanks to Mark Malangoni, MD, for advising us to consider MOC as “a fact of life.” Perhaps he can answer whether the lack of diplomate representation on specialty boards mandating MOC participation is not a form of taxation without representation. And perhaps he could comment on forcing diplomates to participate in this expensive, onerous, procedure of uncertain value. How would he advise diplomates who disagree with many ABMS/specialty society MOC policies to proceed?

Marc S. Frager, MD

Boca Raton, Florida

 

Related Videos
Robert E. Oshel, PhD
Gary Price, MD, MBA
Victor J. Dzau, MD, gives expert advice
Ron Holder, MHA, gives expert advice
remote patient monitoring
referral
no shows
effective meetings
phone
© 2023 MJH Life Sciences

All rights reserved.